Information AboutRadium 223 Dichloride

Overview

A radiopharmaceutical composed of the dichloride salt of the alpha-emitting isotope radium Ra 223, with antineoplastic activity. Like calcium, radium targets bone tissue and preferentially accumulates in osteoblastic lesions, such as those seen in areas of bone metastases. Radium Ra 223 forms complexes with hydroxyapatite and becomes incorporated into the bone matrix. The radioisotope Ra 223 kills bone cancer cells through local emission of high energy alpha particles, causing DNA double-strand breaks and tumor regression in the skeleton. The short range effects of alpha emission allows for localized DNA damage with limited toxicity to nearby healthy bone tissue.

*Source: National Cancer Institute

http://www.cancer.gov/cancertopics/druginfo/prostatecancer

Leave a Comment

 

Education.

Most people don't realize that around 25% of men are diagnosed with cancer during their lifetime, but only 1 in 10 cases are due to genetic defect. Blue Cure knows cancer can be preventable, and we're on a mission to make sure everyone else knows it as well.

Advocacy.

Blue Cure is all about stopping cancer before it starts, and we advocate on behalf of men everywhere for that to happen. We're continually petitioning for awareness and changes in products and lifestyles to decrease the rate of cancer across America and beyond.

Improving Outcomes.

Unfortunately, cancer strikes men all to often. That's why in addition to efforts to preventing cancer, we want to be a resource to men and families living with cancer. Our cancer center map and treatment guides help patients find the best opportunities for a positive outcome.